A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis

NCT00690807 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Provectus Pharmaceuticals